Beger H - Search Results

1

Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1.

Bergmann U, Funatomi H, Kornmann M, Ishiwata T, Beger H, Korc M. Bergmann U, et al. Among authors: beger h. Int J Oncol. 1996 Sep;9(3):487-92. doi: 10.3892/ijo.9.3.487. Int J Oncol. 1996. PMID: 21541539

2

Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Bergmann U, et al. Among authors: beger hg. Cancer Res. 1995 May 15;55(10):2007-11. Cancer Res. 1995. PMID: 7743492

3

Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival.

Kornmann M, Ishiwata T, Itakura J, Tangvoranuntakul P, Beger HG, Korc M. Kornmann M, et al. Among authors: beger hg. Oncology. 1998 Jul-Aug;55(4):363-9. doi: 10.1159/000011879. Oncology. 1998. PMID: 9663429

4

Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells.

Kornmann M, Lopez M, Beger H, Korc M. Kornmann M, et al. Among authors: beger h. Int J Gastrointest Cancer. 2001;29(2):85-92. Int J Gastrointest Cancer. 2001. PMID: 12754391

5

IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.

Kornmann M, Ishiwata T, Matsuda K, Lopez ME, Fukahi K, Asano G, Beger HG, Korc M. Kornmann M, et al. Gastroenterology. 2002 Jul;123(1):301-13. doi: 10.1053/gast.2002.34174. Gastroenterology. 2002. PMID: 12105858

6

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.

Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, Korc M. Friess H, et al. Among authors: beger hg. Gastroenterology. 1993 Dec;105(6):1846-56. doi: 10.1016/0016-5085(93)91084-u. Gastroenterology. 1993. PMID: 8253361

7

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.

Yamanaka Y, Friess H, Kobrin MS, Buchler M, Beger HG, Korc M. Yamanaka Y, et al. Among authors: beger hg. Anticancer Res. 1993 May-Jun;13(3):565-9. Anticancer Res. 1993. PMID: 8317885

8

Increased expression of insulin receptor substrate-1 in human pancreatic cancer.

Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. Bergmann U, et al. Among authors: beger hg. Biochem Biophys Res Commun. 1996 Mar 27;220(3):886-90. doi: 10.1006/bbrc.1996.0500. Biochem Biophys Res Commun. 1996. PMID: 8607861

9

Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions.

Kornmann M, Ishiwata T, Beger HG, Korc M. Kornmann M, et al. Among authors: beger hg. Oncogene. 1997 Sep 18;15(12):1417-24. doi: 10.1038/sj.onc.1201307. Oncogene. 1997. PMID: 9333017

10

Altered expression of insulin-like growth factor II receptor in human pancreatic cancer.

Ishiwata T, Bergmann U, Kornmann M, Lopez M, Beger HG, Korc M. Ishiwata T, et al. Among authors: beger hg. Pancreas. 1997 Nov;15(4):367-73. doi: 10.1097/00006676-199711000-00006. Pancreas. 1997. PMID: 9361090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters